Bladder Cancer Therapy
Recent findings from Zhejiang University, Department of Urology highlight research in bladder cancer therapy
Published in Drug Law Weekly, July 29th, 2008
Data detailed in 'Up-regulation of p21WAF1/Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cells' have been presented. "Very recent studies have reported that chemically synthesized small duplex RNAs complementary to the promoters of target genes can activate gene expression in different cancer cell lines. Such dsRNA have been referred to as saRNA for small activating RNA," researchers in Hangzhou, People's Republic of China report.
"The present study was conducted to evaluate the potential of p21(WAF1/Cip1) (p21) induction by small activating RNA targeting the p21 promoter in the treatment of bladder cancer. Using T24 human bladder...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-07-29)
More Articles from Drug Law Weekly
- Adverse Drug Reactions
Data on adverse drug reactions published by T.R. Deer and colleagues - Amgen
Amgen and Ortho Biotech Settle Antitrust Suit - APEX Analytix
APEX Analytix Grows Its Global Customer Base - AT&T Inc.
New Kentucky Law Helps Police Stem Metal Thefts - Biologics
Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor - Biotech Business
RNCOS Releases a New Report- Booming US Generic Drug Market - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
